A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

Immunoglobulin replacement therapy is the standard-of-care treatment for patients with primary immunodeficiency diseases who have impaired antibody production and function. Clinicians and patients may consider intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) options, and each...

Descripción completa

Detalles Bibliográficos
Autores principales: Epland, Kristin, Suez, Daniel, Paris, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526304/
https://www.ncbi.nlm.nih.gov/pubmed/36180928
http://dx.doi.org/10.1186/s13223-022-00726-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526304/
https://www.ncbi.nlm.nih.gov/pubmed/36180928
http://dx.doi.org/10.1186/s13223-022-00726-7

Ejemplares similares